Скачать или смотреть The Economics of a Pill: Why Medicines Cost Billions Before Saving a Life

Why does a single pill cost billions of dollars before it ever reaches a patient?

In this video, we break down the real economics of a pharmaceutical drug — from early discovery to clinical trials, regulatory approval, and commercial launch.

This is not about pricing headlines.
This is about risk, capital, failure, and survival inside the pharma industry.

In just 5 minutes, you’ll understand:
• Why drug development costs $2–3 billion on average
• Why only 1 out of 5,000–10,000 molecules becomes a medicine
• How failure economics shape drug pricing
• Why clinical trials consume most R&D budgets
• How pharma companies calculate risk vs reward
• Why economics, not chemistry, kills most drugs
• How time, patents, and capital decide patient access

This video explains pharmaceutical economics the way industry insiders, investors, and decision-makers actually think about it — grounded in real data, not opinions.

📊 Key data discussed:
• 10–15+ years average development time
• ~90% clinical trial failure rate
• ~$2.6B cost per approved drug
• Oncology success rates as low as 3–5%

🎯 Who should watch:
• Pharma & biotech professionals
• Clinical research teams
• Pharmacy & medical students
• Healthcare investors
• Anyone curious about why medicines cost what they do

Explore deeper case studies and frameworks:
👉 https://www.prathambawali.com

If this helped you think differently about medicine:
👍 Like
📌 Subscribe
💬 Comment your biggest takeaway

#PharmaEconomics
#DrugDevelopment
#HealthcareEconomics
#Biotech
#PharmaIndustry